摘要
目的研究和探讨氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效。方法选取2012年9月—2014年10月该院收治的80例高血压合并冠心病患者为研究对象,按治疗方法不同分为观察组(40例,氨氯地平阿托伐他汀钙片治疗),对照组(40例,硝苯地平控释片治疗),对比两组患者的治疗效果。结果观察组患者治疗后收缩压、舒张压等血压值及不良反应总发生率均显著低于对照组,差异有统计学意义(P<0.05);观察组患者治疗总有效率显著高于对照组,差异有统计学意义(P<0.05)。结论氨氯地平阿托伐他汀钙片治疗高血压合并冠心病,可降低血压,提高治疗总有效率,减少不良反应发生,临床可广泛应用。
Objective This paper is to investigate and discuss clinical efficacies of Amlodipine Atorvastatin Calcium Tablets in treating hypertension accompanying with coronary heart disease（CHD）. Methods Eighty patients with hypertension accompanying with coronary heart disease admitted by the Hospital from September, 2012 to October, 2014 were selected as research subjects,who were divided into the observation group（40 cases, subject to Amlodipine Atorvastatin Calcium Tablets treatment） and control group（40 cases, subject to Nifedipine Controlled Release Tablets treatment） according to different treatment methods, and efficacies on patients in two groups were compared. Results The total incidence rates of systolic blood pressure, diastolic blood pressure, blood pressure and adverse reactions of patients in observation group after treatment were significantly lower than those of patients in control group, and the differences were statistically significant（P〈0.05）. The total effective rate on patients in the observation group was significantly higher than that on patients in the control group, and the difference was statistically significant（P〈 0.05）.Conclusion Amlodipine Atorvastatin Calcium Tablets applied to treat patients with hypertension accompanying with coronary heart disease is capable of decreasing the blood pressure, improving the total effective rate, and reducing the occurrence of adverse reactions, being worthy of wide application in clinic practices.
出处
《中外医疗》
2015年第15期94-95,共2页
China & Foreign Medical Treatment
关键词
氨氯地平
阿托伐他汀钙片
高血压
冠心病
Amlodipine
Atorvastatin Calcium Tablets
Hypertension
Coronary Heart Disease
